文献速递临床试验与 GCP流行病学与生物统计

结构化与自主多领域生活方式干预对整体认知功能的影响:美国POINTER随机临床试验

Structured vs Self-Guided Multidomain Lifestyle Interventions for Global Cognitive Function: The US POINTER Randomized Clinical Trial.
PubMed 文献 · JAMA · 2025-01-01

这项单盲、多中心随机临床试验纳入2111名有认知下降风险的60-79岁老年人,比较结构化与自主多领域生活方式干预2年对整体认知轨迹的影响。结构化组整体认知复合z评分年均增加0.243 SD,自主组为0.213 SD,组间差异为每年0.029 SD(95%CI 0.008-0.050;P=0.008),结构化干预获益更大。

要点

  • 结构化组整体认知复合z评分年均增加0.243 SD,自主组为0.213 SD,组间差异0.029 SD/年(P=0.008)。
  • 结构化干预获益在APOE ε4携带者与非携带者中一致(交互P=0.95),在基线认知较低者中似乎更大(交互P=0.02)。
  • 结构化组报告的不良事件少于自主组:严重事件151 vs 190,非严重事件1091 vs 1225。

核心结论

  • 在有认知下降和痴呆风险的老年人中,结构化、较高强度的干预相比非结构化、自主引导的干预对整体认知有统计学显著更大的获益。
  • 作者指出需进一步研究功能结局、生物标志物及延长随访,以明确所观察认知获益的临床相关性和可持续性。

研究设计与样本

  • 单盲、多中心随机临床试验,2019年5月至2023年3月在美国5个临床中心入组2111名参与者,最终随访至2025年5月14日。
  • 参与者年龄60至79岁、久坐生活方式、饮食不理想,并至少满足2项额外标准(记忆损害家族史、心血管代谢风险、种族和族裔、较大年龄、性别)。
  • 参与者以等概率随机分配至结构化干预组(n=1056)或自主引导干预组(n=1055)。
  • 两组均鼓励增加体育和认知活动、健康饮食、社交参与和心血管健康监测,但在结构、强度和问责制方面不同。

主要发现

  • 2111名入组者平均年龄68.2岁(SD 5.2),女性1455名(68.9%),89%完成第2年评估。
  • 两组整体认知复合z评分自基线随时间平均增加,结构化组年均增加0.243 SD(95%CI 0.227-0.258),自主组年均增加0.213 SD(95%CI 0.198-0.229)。
  • 结构化组年均增加率比自主组高0.029 SD(95%CI 0.008-0.050;P=0.008),差异有统计学显著性。
  • 预设亚组比较显示,结构化干预获益在APOE ε4携带者与非携带者中一致(交互P=0.95),在基线认知较低者中似乎大于基线认知较高者(交互P=0.02)。
  • 结构化组报告的不良事件少于自主组:严重事件151 vs 190,非严重事件1091 vs 1225;COVID-19检测阳性为总体最常见不良事件,且在结构化组更频繁。

局限性

  • 作者指出需进一步研究功能结局、生物标志物及延长随访,以明确所观察认知获益的临床相关性和可持续性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Identifying new interventions to slow and prevent cognitive decline associated with dementia is critical. Nonpharmacological interventions targeting modifiable risk factors are promising, relatively low-cost, accessible, and safe approaches. OBJECTIVE: To compare the effects of two 2-year lifestyle interventions on cognitive trajectory in older adults at risk of cognitive decline and dementia. DESIGN, SETTING, AND PARTICIPANTS: Single-blind, multicenter randomized clinical trial enrolling 2111 participants from May 2019 to March 2023 (final follow-up, May 14, 2025) at 5 clinical sites in the US. Participant inclusion criteria enriched risk of cognitive decline and included age 60 to 79 years, sedentary lifestyle, and suboptimal diet plus at least 2 additional criteria related to family history of memory impairment, cardiometabolic risk, race and ethnicity, older age, and sex. INTERVENTIONS: Participants were randomly assigned with equal probability to structured (n = 1056) or self-guided (n = 1055) interventions. Both interventions encouraged increased physical and cognitive activity, healthy diet, social engagement, and cardiovascular health monitoring, but differed in structure, intensity, and accountability. MAIN OUTCOMES AND MEASURES: The primary comparison was difference between intervention groups in annual rate of change in global cognitive function, assessed by a composite measure of executive function, episodic memory, and processing speed, over 2 years. RESULTS: Among the 2111 individuals enrolled (mean age, 68.2 [SD, 5.2] years; 1455 [68.9%] female), 89% completed the year 2 assessment. The mean global cognitive composite z score increased from baseline over time in both groups, with a mean rate of increase per year of 0.243 SD (95% CI, 0.227-0.258) for the structured intervention and 0.213 SD (95% CI, 0.198-0.229) for the self-guided intervention. The mean rate of increase per year was statistically significantly greater for the structured group than the self-guided group by 0.029 SD (95% CI, 0.008-0.050; P = .008). Based on prespecified secondary subgroup comparisons, the structured intervention benefit was consistent for APOE ε4 carriers and noncarriers (P = .95 for interaction) but appeared greater for adults with lower vs higher baseline cognition (P = .02 for interaction). Fewer ascertained adverse events were reported in the structured group (serious: 151; nonserious: 1091) vs the self-guided group (serious: 190; nonserious: 1225), with a positive COVID-19 test result being the most common adverse event overall and more frequent in the structured group. CONCLUSIONS AND RELEVANCE: Among older adults at risk of cognitive decline and dementia, a structured, higher-intensity intervention had a statistically significant greater benefit on global cognition compared with an unstructured, self-guided intervention. Further investigation of functional outcomes, biomarkers, and ongoing extended follow-up will help address clinical relevance and sustainability of the observed cognitive benefits. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT03688126.

来源:JAMA,查看原文。版权归原作者所有。

引用

  1. Baker LD, Espeland MA, Whitmer RA, et al. Structured vs Self-Guided Multidomain Lifestyle Interventions for Global Cognitive Function: The US POINTER Randomized Clinical Trial. JAMA. 2025. PMID: 40720610. doi:10.1001/jama.2025.12923

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。